High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$847K
$847,514
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BBNX
S
Beta Bionics, Inc.
Hopman Mark
• Officer • Chief Commercial Officer
10b5-1 Sell
2026-03-04
$4,084
|
||||||
| BBNX |
Beta Bionics, Inc.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2026-03-04 | $4,084 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $17,652 | S | Form 4 |
|
BBNX
S
Beta Bionics, Inc.
Mensinger Mike
• Officer • Chief Product Officer
Sell to Cover
2026-03-02
$13,153
|
||||||
| BBNX |
Beta Bionics, Inc.
|
Officer • Chief Product Officer
Sell to Cover
|
2026-03-02 | $13,153 | S | Form 4 |
|
BBNX
S
Beta Bionics, Inc.
Hopman Mark
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-02
$10,310
|
||||||
| BBNX |
Beta Bionics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $10,310 | S | Form 4 |
|
BBNX
S
Beta Bionics, Inc.
Russell Steven Jon
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$12,683
|
||||||
| BBNX |
Beta Bionics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $12,683 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $41,832 | S | Form 4 |
|
BBNX
S
Beta Bionics, Inc.
Mensinger Mike
• Officer • Chief Product Officer
Sell to Cover
2025-12-02
$31,184
|
||||||
| BBNX |
Beta Bionics, Inc.
|
Officer • Chief Product Officer
Sell to Cover
|
2025-12-02 | $31,184 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
Sell to Cover
|
2025-12-02 | $41,862 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CEO
Sell to Cover
|
2025-12-02 | $96,163 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $26,588 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $14,955 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $26,570 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $14,982 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 SellΔOwn -12.2%
|
2025-10-31 | $36,727 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 Sell
|
2025-10-31 | $1,053 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 Sell
|
2025-10-31 | $3,267 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
Director
10b5-1 SellΔOwn -11.4%
|
2025-10-31 | $34,567 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
Other
|
2025-10-03 | $25,408 | M | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
10b5-1 Sell
|
2025-10-03 | $82,368 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
10b5-1 Sell
|
2025-10-03 | $25,709 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
10b5-1 SellΔOwn -25.3%
|
2025-10-01 | $309,698 | S | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
Other
|
2025-10-01 | $76,592 | M | Form 4 |
| BBNX |
Beta Bionics, Inc.
|
CFO
10b5-1 Sell
|
2025-10-01 | $2,108 | S | Form 4 |